| Incensole acetate prevents beta-amyloid-induced neurotoxicity in human olfactory bulb neural stem cells MA El-Magd, SF Khalifa, FAA Alzahrani, AA Badawy, ES El-Shetry, ... Biomedicine & Pharmacotherapy 105, 813-823, 2018 | 24 | 2018 |
| Altered expression of some miRNAs and their target genes following mesenchymal stem cell treatment in busulfan-induced azoospermic rats MMA Abdelnaser A. Badawyae, Mohammed A. El-Magdb, Sana A. AlSadrahc Gene 737, 2020 | 20 | 2020 |
| Selective therapeutic strategy for p53-deficient cancer by targeting dysregulation in DNA repair J Zonneville, M Wang, MM Alruwaili, B Smith, M Melnick, KH Eng, ... Communications biology 4 (1), 862, 2021 | 10 | 2021 |
| Camel milk exosomes potentiate the anticancer effect of doxorubicin on multidrug-resistant human leukemia Hl60 cells in vitro and in vivo R Othman, A Badawy, M Alruwaili, M El-Magd Pak. J. Med. Health Sci 15, 3313-3320, 2021 | 8 | 2021 |
| A synergistic two-drug therapy specifically targets a DNA repair dysregulation that occurs in p53-deficient colorectal and pancreatic cancers MM Alruwaili, J Zonneville, MN Naranjo, H Serio, T Melendy, ... Cell Reports Medicine 5 (3), 2024 | 4 | 2024 |
| ABCA1 gene polymorphism and oxidative stress in polycystic ovary syndrome: Role of antioxidant therapy for prevention and control R Monir, A Badawy, N Mokhtar, H Nabil, M Alruwaili Bulletin of Egyptian Society for Physiological Sciences 37 (2), 143-153, 2017 | 2 | 2017 |
| YIA24-003: A Phase I Study of TAS102 Plus Talazoparib in Advanced Colorectal (CRC) and Esophagogastric (EGC) Adenocarcinomas C Fountzilas, A Witkiewicz, S Chatley, V Fitzpatrick, J Zonneville, ... Journal of the National Comprehensive Cancer Network 22 (2.5), 2024 | | 2024 |
| The role of p38 MAPK in the tumor-induced immune suppressive microenvironment in metastatic breast cancer P Rajan, R Zollo, M Lieberman, Y Guo, M Alruwaili, M Alqarni, B Morreale, ... Cancer Research 84 (6_Supplement), 5536-5536, 2024 | | 2024 |
| Novel therapeutic approach for targeting p53 mutant colorectal cancers by affecting post-replicative DNA repair MM Alruwaili, N Naranjo, P Rajan, KB Jo, DK Kim, T Melendy, ... Cancer Research 84 (6_Supplement), 7590-7590, 2024 | | 2024 |
| Blockade of p38 MAPK reduces the tumor-induced immune suppressive microenvironment in metastatic breast cancer P Rajan, J Zonneville, R Zollo, M Honikel, S Raudins, S Colligan, ... Cancer Research 83 (7_Supplement), 73-73, 2023 | | 2023 |
| Evaluation of a novel two-drug combination strategy for p53-deficient colorectal and pancreatic cancers MM Alruwaili, J Zonneville, MA Alqarni, P Rajan, H Serio, R Straubinger, ... Cancer Research 83 (7_Supplement), 3397-3397, 2023 | | 2023 |
| Development of a selective therapeutic intervention for p53 mutant for pancreatic adenocarcinoma. MM Alruwaili, J Zonneville, MA Alqarni, P Rajan, H Serio, R Straubinger, ... CANCER RESEARCH 82 (22), 83-84, 2022 | | 2022 |
| Abstract B039: Development of a selective therapeutic intervention for p53 mutant for pancreatic adenocarcinoma MM Alruwaili, J Zonneville, MA Alqarni, P Rajan, H Serio, R Straubinger, ... Cancer Research 82 (22_Supplement), B039-B039, 2022 | | 2022 |
| Abstract P1-16-07: A synthetic lethality treatment strategy for p53 mutant breast cancer A Bakin, J Zonneville, M Wang, M Alruwaili, K Eng, R Iyer, B Park, ... Cancer Research 82 (4_Supplement), P1-16-07-P1-16-07, 2022 | | 2022 |
| A novel synthetic lethality treatment strategy for metastatic breast cancer J Zonneville, M Wang, M Alruwaili, K Eng, T Melendy, BH Park, R Iyer, ... Cancer Research 81 (13_Supplement), 1180-1180, 2021 | | 2021 |
